Ledger.Open graph →
SEC Form D · filed April 9, 2024

PharmaCann Inc

Offering
$27.7M
Sold
$27.7M
Exemption
Rule 506(b)
Industry
Other
Location
CHICAGO, IL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Patrick P. Unzicker · Chicago, ILExecJohn P. Lord · Chicago, ILDirectorBrett Novey · Chicago, ILExec · DirectorLori P. Richards · Chicago, ILDirectorRobert P. Mcqueen · Chicago, ILExecJohn P. Mccarthy · Chicago, ILDirectorJames P. Barry · Chicago, ILDirectorStephen P. Schuler · Chicago, ILDirectorMark Mccurdy, M.D · Fort Worth, TXDirectorIan Balina · Beaverton, ORDirectorJeff Spain · Rialto, CAExecJeff N. Lucassen · TORONTO, Ontario, CanadaDirectorKatherine N. Gurney · TORONTO, Ontario, CanadaExecJustin J. Dennis · Jacksonville, FLDirectorAndrew T. Messer · Jacksonville, FLExec · DirectorRafael La Porta De Castro · Rialto, CADirectorBruce R. Jenkyn-Jones · London, United KingdomDirectorEdward Shehwen · Mt. Laurel, NJExec · DirectorParent of the General Partner Richard Impax Asset Management Group PLC · London, United KingdomDirectorKen Johnson · Mt. Laurel, NJExecBernd B. Gottschalk · Pleasanton, CAExecJonathon B. Husby · Pleasanton, CADirectorJeff Mcdermott · Fargo, NDDirectorMatthew Fisch · Pleasanton, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗